ContextVision is now offering an image-enhancement solution, which allows for the radiation dose to be lowered substantially, without impairing the image quality of the captured x-rays. By applying ContextVision's patented GOP image processing software technology on CT images, the radiation dose can be substantially reduced with maintained image quality.
Furthermore, when lowering the radiation dose associated with each x-ray, the useful lifetime of an x-ray tube is also increased substantially, leading to significant cost savings to hospitals. Clinical evaluations of ContextVisions solution for CT Dose Reduction are ongoing at several hospitals in the United States and Europe and are expected to be completed during first quarter 2006.
The agreement with Medirad Scandinavia calls for initial deliveries to pilot hospitals in Norway during the first quarter 2006. These hospitals will evaluate the product in a production environment and ensure that work flow is maintained. Regular customer deliveries, also to hospitals in Norway and Sweden, are expected to be started during the second quarter 2006. Medirad Scandinavia will be responsible for integration, installation and support of the product towards the hospitals.
"We are delighted to establish a close co-operation with Medirad Scandinavia as a first step in launching our unique CT Dose Reduction product. With Medirad's proven knowledge of and long experience in the Norwegian medical imaging market, we are confident that the launch will be successful and will meet our customers' expectations", stated Jan Erik Hedborg, CEO of ContextVision.
"We are extremely enthusiastic about being the first to introduce a modality independent CT Dose Reduction. This is a break-through solution which will reduce patient concerns for unhealthy radiation exposure", stated Peter A. Wasa, the CEO of Medirad Scandinavia AS. "ContextVision offers a revolutionary technology solution for our customers."
ContextVision is an independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for over 15 years. ContextVision's patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound and CT image data. ContextVision's technology enables the company's customers to provide superior digital imaging quality for hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. ContextVision's embedded imaging software is relied upon daily by thousands of users around the globe.
Medirad AS was founded by the Wasa family in 1972 to distribute medical imaging products for GE Medical Systems in Norway. Medirad AS, was sold to GE Q4, 2000. Medirad Scandinavia was founded in 1989, as part of the Medirad Group and was chartered to produce, import and sell other complimentary medical imaging products. Medirad grew to become the leading medical imaging company in Norway, a market earlier dominated by European manufacturers.